Dietary deficiency of saturated fats and cholesterol. Yes, you read it right. Low intake of saturated fat is factor in increasing your risk of heart disease. The following facts on saturated fats are from Mary G. Enig, PhD president of the Price-Pottenger Nutrition Foundation.
a) Saturated fatty acids raise HDL, the so-called good cholesterol, whereas the trans fatty acids lower HDL cholesterol.
b) Saturated fatty acids lower the blood levels of the atherogenic lipoprotein (a), whereas trans fatty acids raise the blood levels of Lp(a)
c) Saturated fatty acids conserve the good omega-3 fatty acids whereas trans fatty acids cause the tissues to lose the good omega-3 fatty acids.
d) Saturated fatty acids do not inhibit insulin binding whereas trans fatty acids do inhibit insulin binding.
e) Saturated fatty acids are the normal fatty acids made by the body and they do not interfere with enzyme functions such as the delta-6-desaturase, whereas trans fatty acids are not made by the body and they interfere with many enzyme functions such as delta-6-desaturase.
f) Some saturated fatty acids are used by the body to fight viruses, bacteria and protozoa and they support the immune system whereas trans fatty acids interfere with the function of the immune system.
g) Stearic acid, a naturally saturated fatty acid, is the preferred food for the heart whereas trans fatty acids replace these saturated fatty acids in the cell membrane, thus depriving the heart of its optimum energy source.
h) Saturated fatty acids are needed for proper modeling of calcium in the bones whereas trans fatty acids cause softening of the bones.
i) Saturated fatty acids from animal sources are carriers for vital fat-soluble vitamins whereas factory-produced trans fatty acids are devoid of these important nutrients.
Thyroid functional evaluationDo see the significance of the two lists you have just read?
The knowledge you have in the first list puts you far above the vast majority of people in your understanding of CVD causes.
As unbelievable as it may seem, we have a condition that kills more than 50% of all people, yet most doctors are almost entirely ignorant of the causes of this condition. How unbelievably absurd is that? You can be quite pleased that you have risen above the standards of mediocrity that characterize the healing arts professions.
The real beauty is in the second list. Here, you have best clinical indicators that inform you completely about the 19 causative factors of CVD.
Do you see how valuable this is to you and your loved ones? You have the ability to define and monitor the 19 causes of cardiovascular disease with best clinical indicators.
Case History
Peter is a 58 years old and he already had one heart attack. His triglycerides were over 1000, blood pressure in the stratosphere, and his pulse would bounce up to over 100 at the slightest provocation. Peter was found to have 14 of the 20 causes of cardiovascular disease.
Functional Diagnostic Testing provided valuable objective information helping me to formulate a personalized program.
Within three months, Peter's triglycerides came down below 200, the blood pressure was in the high normal and his pulse was steady and strong. Furthermore, Peter was able to eliminate four of his six medications prescribed by the Cardiologist, and is feeling better than he has in years. Overall, Peter's risk factors went from 14 to 6.
==========
Overview of Risk Factors and Clinical Testing
Dr. Grisanti's comments:
Would you like to know if you are at risk to get a heart attack or stroke?
Identifying your risk factors allows you to identify early stages of CVD 20 years or more before the typical physician will identify a pathology, and as much as 25-30 years before the heart attack or stroke.
Remember, cholesterol "alone" is simply not acceptable. Don't buy into the Madison Avenue million dollar television ads telling you that lowering your cholesterol will save you from having a stroke or heart attack.
Now that you know the truth, do something about it and demand that your physician properly evaluates your risk factors.
It could mean the difference between life and death!
In part 3 I will discuss the best and most researched treatment to reverse and prevent the 19 risk factors.
References:
Filipovsky J, Ducimetaere P, Eschwaege E, Richard JL, Rosselin G, Claude JR. The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men. J Hypertens 1996;14(2):229-35.
Fredrickson M, Tuomisto M, Bergman-Losman B. Neuroendocrine and cardiovascular stress reactivity in middle-aged normotensive adults with parental history of cardiovascular disease. Psychophysiol 1991;28(6):656-64.
Stahl F, Schnorr D, Pilz C, Dörner G. Dehydroepiandrosterone (DHEA) levels in patients with prostatic cancer, heart diseases and under surgery stress. Exp Clin Endocrin 1992;99:68-70.
English KM, Steeds R, TH Jones, Channer KS. Testosterone and coronary heart disease: is there a link? QJM 1997;90:787-791.
Phillips GB, Pinkernell BH, Tian-Yi J. The association of hypotesteronemia with coronary artery disease in men. Arterioscler Thromb 1994;14(5):701-706.
Chute CG, Baron JA, Plymate SR, Kiel DP, Pavia AT, et. al. Sex hormones and coronary artery disease. Am J Med 1987;853-859.
Sewdarsen M, Vythilingum S, Jialil I, Desai RK, Becker P. Abnormalities in sex hormones are a risk factor for premature manifestation of coronary artery disease in South African Indian men. Atherosclerosis 83:111-117.
Alexandersen P, Haarbo J, Christiansne C. The relationship of natural androgens to coronary heart disease in males: a review. Athersclerosis 1996;125(1-13).
Stampfer MJ, Malinow MR, Willet WC, Newcomer LM, Upson B, Ullmann D, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992;268(7):877-881.
Miller AL, Kelly GS. Homocysteine Metabolism: Nutritional modulation and impact on health and disease. Alt Med Rev 1997;2(4):234-254.
Hiraga T, Shimada M, Tsukada T, Murase T. Hypertriglyceridemia, but not hypercholesterolemia, is associated with the alterations of fibrinolytic system. Horm Metab Res 1996; 28(11):603-6.
Davignon J, Cohn JS. Triglycerides: a risk factor for coronary heart disease. Atherosclerosis 1996;124:S57-64.
Frohlich JJ. Lipoproteins and homocysteine as risk factors for atherosclerosis: assessment and treatment. Can J Cardiol 1995:11(Suppl C): 18C-23C.
Grau AJ, Buggle F, Beeher H,etal. The association of leukocyte count, fibrinogen, and c-reactive protein with vascular risk factors and ischemic vascular diseases. Thromb Res 1996; 82(3):245-255.
Ridker PM, Cushman M, Stampher MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336(14):973-9.
Assman G, Schulte H. Triglycerides and atherosclerosis: results from the prospective cardiovascular Münster study. Atheroscler Rev 1991; 22:51-63.
National Institutes of Health:Conference Statement: Triglyceride High Sensity Lipoprotein and Coronary Heart Disease. JAMA 1993;269:505-510.
Researched and Written on April 4, 2004